Results 1 to 10 of about 469 (112)
Evaluation of the theoretical risk of cross-reactivity among recently identified food allergens for dogs. [PDF]
Vet Dermatol, 2022 Background: There is increasing evidence of cross‐reactivity between allergens of close or distant species. The A‐RISC (Allergens'–Relative Identity, Similarity and Cross‐reactivity) index helps evaluate the risk of theoretical cross‐reactivity between proteins of the same family among different species.
Olivry T, O'Malley A, Chruszcz M.
europepmc +2 more sources
Declaración de alergenos en el etiquetado de alimentos: panorama latinoamericano [PDF]
Revista Panamericana de Salud PúblicaObjetivo. Identificar los países que tienen legislación relacionada con la declaración obligatoria de alergenos alimentarios, alimentos irradiados y transgénicos en el etiquetado nutricional de alimentos envasados. Métodos.
Patricia Caro, Clara Elvers
doaj +2 more sources
Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases. [PDF]
Vet Dermatol, 2022 Background –Canine atopic dermatitis (cAD) is an allergic skin disease affecting approximately 10% of dogs. Allergen immunotherapy (AIT) is currently the only treatment option able to induce tolerance to the causative allergens. Objective – To retrospectively establish the efficacy of AIT in atopic dogs.
Fennis EEM +6 more
europepmc +2 more sources
An international seroprevalence survey of the IgE sensitisation to the Dermatophagoides farinae house dust mite and two of its major allergens (Der f 2, Zen 1) in atopic dogs. [PDF]
Vet Dermatol, 2022 Background – Dogs with atopic dermatitis are often immunoglobulin (Ig)E‐sensitised to Dermatophagoides farinae (Df) house dust mites, yet limited data exist on the sensitisation rates to the individual Df allergens, Der f 2 and Zen 1. Objectives – To determine the IgE sensitisation rates to Df, Der f 2 and Zen 1 in atopic dogs from geographically ...
Favrot C, Olivry T, Iwasaki T.
europepmc +2 more sources
A prospective study evaluating the correlation between local weather conditions, pollen counts and pruritus of dogs with atopic dermatitis. [PDF]
Vet DermatolAbstract Background Canine atopic dermatitis (cAD) is a hereditary, generally pruritic and predominantly T‐cell‐driven inflammatory skin disease, involving an interplay between skin barrier abnormalities, allergen sensitisation and microbial dysbiosis.
Widorn L, Zabolotski Y, Mueller RS.
europepmc +2 more sources
Immunotherapy using pullulan-conjugated Der f 2 allergen in canine atopic dermatitis: An anti-inflammatory agent-sparing approach. [PDF]
Vet DermatolBackground – Allergen immunotherapy is used as aetiological treatment for canine atopic dermatitis (cAD). Objective – To assess the anti‐inflammatory agent‐sparing effect over 1 year of immunotherapy using pullulan‐conjugated recombinant Der f 2 (rDf2‐P). Conclusions and Clinical Relevance – Der f 2‐P immunotherapy can lead to a rapid reduction in anti‐
Nagata M +7 more
europepmc +2 more sources
Veterinary Dermatology, Volume 34, Issue 6, Page 543-553, December 2023., 2023 Background – Hymenoptera envenomation with honey bee (Apis mellifera) and paper wasp (Polistes spp.) may cause life‐threatening anaphylaxis in dogs. In human patients, clinical history, intradermal testing (IDT) and measurement of allergen‐specific serological immunoglobulin (Ig)E (sIgE) are used to support a diagnosis of Hymenoptera venom ...
Hilary H. Chan +3 more
wiley +1 more source
Veterinary Dermatology, Volume 34, Issue 5, Page 393-403, October 2023., 2023 Background – Grass leaf has been suspected to cause immunoglobulin (Ig)E‐mediated immediate hypersensitivity reactions both in humans and in dogs. However, most studies in this area are case control studies without in vitro data showing the involvement of IgE in the reaction.
Ken Mason, Janet Davies, Merja Ruutu
wiley +1 more source
The safety of rush immunotherapy in the management of canine atopic dermatitis—230 cases
Veterinary Dermatology, Volume 34, Issue 5, Page 385-392, October 2023., 2023 Background – The duration of the induction phase of allergen‐specific immunotherapy conventionally is a period of several weeks, during which the volume of an allergen solution, administered by injection, is gradually increased until the maintenance dose is reached.
Tamara Weitzer, Ralf Mueller
wiley +1 more source
Revista Médica de la Universidad de Costa Rica, 2023 Actualmente en Costa Rica, el acceso a la información sobre contenido de gluten, lactosa y otros alérgenos en medicamentos es limitada, lo que dificulta el uso seguro de éstos por parte de las personas con condiciones de salud asociadas a estas ...
María Laura Bonilla-Acosta +9 more
doaj +1 more source